Surgical technique was the only available option as a treatment of AMD until the discovery of stem cells. Stem cells technology has changed the approach as the only available non-surgical method that can reverse the damage and stop the progression of the AMD.
Stem cells are the cells of the body with the capacity to differentiate into cells of different organs. The worldwide ongoing research has suggested that stem cells represent the most promising way to replace degenerated or damaged RPE (Retinal Pigment Epithelial) cells. This is believed to halt or reverse the vision loss associated with the AMD.
At Cellebration, we have mastered the technology for isolating the maximum number of viable stem cells from either an autologous source or an allogenic source from a matched donor.
Stem Cell treatment for AMD involves administration of concentrated cells into the targeted area to form colonies, adapt the properties of resident stem cells, and initiate some of the lost functions that have been compromised by the disease or injury.
These cells are administered through one of the methods after a considerably analysis of patient’s unique history.
Retrobulbar Administration
In this mode, cells are infused directly in the retina of the eye.
Intravenous Administration
In this delivery mode, cells are infused into the peripheral veins to expand blood volumes in the system, to ensure that the maximum number of cells are reaching the targeted area.
Once infused back into the body, these cells can create a microenvironment necessary for replacing dead or damaged cells of the macula with fresh cells.
Stem cells are also known to have vasculogenetic properties with which they can induce new blood vessel formation replacing leaky or damaged vessels of the eye. With our standardized, broad based and holistic approach, it is now possible to obtain noticeable improvements and stoppage of progression in patients with AMD.